257 related articles for article (PubMed ID: 9637888)
1. [Hemostatic evaluation of a patient with haloperidol-induced neuroleptic malignant syndrome associated with disseminated intravascular coagulation].
Seki Y; Takahashi H; Aizawa Y
Rinsho Ketsueki; 1998 May; 39(5):374-8. PubMed ID: 9637888
[TBL] [Abstract][Full Text] [Related]
2. Serum cytokine level and production of reactive oxygen species (ROS) by blood neutrophils from a schizophrenic patient with hypersensitivity to neuroleptics.
Kamińska T; Szuster-Ciesielska A; Wysocka A; Marmurowska-Michałowska H; Dubas-Slemp H; Kandefer-Szerszeń M
Med Sci Monit; 2003 Jul; 9(7):CS71-5. PubMed ID: 12883457
[TBL] [Abstract][Full Text] [Related]
3. [Rhabdomyolysis and acute renal failure caused by haloperidol-decanoate (neuroleptic malignant syndrome)].
Lazzarin M; Benati F; Cesario V
Recenti Prog Med; 1996 Sep; 87(9):422-4. PubMed ID: 9053957
[TBL] [Abstract][Full Text] [Related]
4. [A study of neuroleptic malignant syndrome in the presenium and senium].
Suzuki I; Honma H; Watanabe N; Matsubara S; Koyama T
Seishin Shinkeigaku Zasshi; 1998; 100(6):387-97. PubMed ID: 9745353
[TBL] [Abstract][Full Text] [Related]
5. [Successful treatment of levodopa-induced neuroleptic malignant syndrome (NMS) with disseminated intravascular coagulation (DIC) in a patient with Parkinson's disease].
Yamawaki Y; Ogawa N
Rinsho Shinkeigaku; 1991 Jan; 31(1):62-7. PubMed ID: 2044308
[TBL] [Abstract][Full Text] [Related]
6. Neuroleptic malignant syndrome versus serotonin syndrome: the search for a diagnostic tool.
Sokoro AA; Zivot J; Ariano RE
Ann Pharmacother; 2011 Sep; 45(9):e50. PubMed ID: 21878660
[TBL] [Abstract][Full Text] [Related]
7. [A successfully treated parkinsonian patient with neuroleptic malignant syndrome complicated by status epilepticus and disseminated intravascular coagulation].
Osoegawa M; Motomura S; Yamanaka H; Tamura K; Miyoshi T
Rinsho Shinkeigaku; 1999 Jun; 39(6):653-7. PubMed ID: 10502992
[TBL] [Abstract][Full Text] [Related]
8. [Elevated levels of cytokines in plasma from patients with disseminated intravascular coagulation].
Wada H; Tamaki S; Tanigawa M; Takagi M; Iwasaki E; Mori Y; Deguchi A; Tsukada T; Kageyama S; Kobayashi T
Rinsho Ketsueki; 1990 Oct; 31(10):1622-5. PubMed ID: 2255053
[TBL] [Abstract][Full Text] [Related]
9. No interplay between the pathways mediating coagulation and inflammation in tissue factor-induced disseminated intravascular coagulation in rats.
Ontachi Y; Asakura H; Takahashi Y; Hayashi T; Arahata M; Kadohira Y; Maekawa M; Omote M; Yoshida T; Yamazaki M; Morishita E; Miyamoto K; Nakao S
Crit Care Med; 2006 Oct; 34(10):2646-50. PubMed ID: 16932226
[TBL] [Abstract][Full Text] [Related]
10. Classification system of complications in neuroleptic malignant syndrome.
Taniguchi N; Tanii H; Nishikawa T; Miyamae Y; Shinozaki K; Inoue Y; Morihara T; Nakano Y; Nishimura T; Takeda M
Methods Find Exp Clin Pharmacol; 1997 Apr; 19(3):193-9. PubMed ID: 9203169
[TBL] [Abstract][Full Text] [Related]
11. [A case of neuroleptic malignant syndrome developed in liver cirrhosis patient addicted to alcohol].
Minamisawa S; Tezuka T; Enomoto K; Nozaki Y; Funatomi H; Hatta Y
Arukoru Kenkyuto Yakubutsu Ison; 1991 Oct; 26(5):367-72. PubMed ID: 1772376
[TBL] [Abstract][Full Text] [Related]
12. Neuroleptic malignant syndrome complicated by disseminated intravascular coagulation.
Eles GR; Songer JE; DiPette DJ
Arch Intern Med; 1984 Jun; 144(6):1296-7. PubMed ID: 6732389
[TBL] [Abstract][Full Text] [Related]
13. Detection and management of the neuroleptic malignant syndrome.
Bond WS
Clin Pharm; 1984; 3(3):302-7. PubMed ID: 6145537
[TBL] [Abstract][Full Text] [Related]
14. [Activation of coagulation and fibrinolysis in patients with abdominal true aortic aneurysm associated with disseminated intravascular coagulation].
Akaike M; Yokoi K; Wada M; Sebe T; Shigekiyo T; Kawai H; Saito S
Kokyu To Junkan; 1993 Mar; 41(3):267-70. PubMed ID: 8469833
[TBL] [Abstract][Full Text] [Related]
15. Plasma level of IL-1 beta in disseminated intravascular coagulation.
Wada H; Tamaki S; Tanigawa M; Takagi M; Mori Y; Deguchi A; Katayama N; Yamamoto T; Deguchi K; Shirakawa S
Thromb Haemost; 1991 Apr; 65(4):364-8. PubMed ID: 2057918
[TBL] [Abstract][Full Text] [Related]
16. Neuroleptic malignant syndrome with renal and respiratory complications--a case report.
Liam CK; Ong SB
Singapore Med J; 1990 Apr; 31(2):182-4. PubMed ID: 1973548
[TBL] [Abstract][Full Text] [Related]
17. Neuroleptic malignant syndrome: a case report.
Fekadu A; Wakwoya A
Ethiop Med J; 1999 Jul; 37(3):195-8. PubMed ID: 11957317
[TBL] [Abstract][Full Text] [Related]
18. [A case of Satoyoshi syndrome with symptoms resembling neuroleptic malignant syndrome].
Adachi H; Riku S; Fujishiro K; Kuru S
Rinsho Shinkeigaku; 1998 Jul; 38(7):637-40. PubMed ID: 9868307
[TBL] [Abstract][Full Text] [Related]
19. [Malignant neuroleptic syndrome associated with myocardial infarction, acute renal insufficiency and rhabdomyolysis].
Benatar Haserfaty J; García Pérez del Río J; Román Tabernero M; Durán Insúa F; Ascorve Domínguez A
Rev Esp Anestesiol Reanim; 1991; 38(4):261-4. PubMed ID: 1685257
[TBL] [Abstract][Full Text] [Related]
20. Neuroleptic malignant syndrome and dopaminergic blockade.
Hashimoto F; Sherman CB; Jeffery WH
Arch Intern Med; 1984 Mar; 144(3):629-30. PubMed ID: 6703834
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
